Home | Sitemap | Imprint
 
Search:
 
 
   
DGRA INTRANET
 
   
Internal information for members.
Name:
Password:
Forgotten your password?
   
BUSINESS OFFICE:
 
   
Adenauerallee 15
D-53111 Bonn,
Germany

Phone: +49 (0)228 368264-6
Fax: +49 (0)228 368264-7
E-Mail: info@dgra.de
 
DRUG REGULATORY AFFAIRS COURSE
Module 4: General aspects of Module 1 (CTD) and authorisation of specific medicines

Method of examination: Course work
Credit points: 5

Module Head: Dr. Christine Mayer-Nicolai

1  

Abridged / Generic Applications with emphasis on administrative processes and content of the dossier in module 1 

  • Essentially similar and informed consent applications
  • Bibliographical Application
  • Content of the dossier (modules 1, 2 and specific aspects for modules 3 and 4)
  • Line-extensions
  • Scientific Advice at the BfArM
  • The marketing authorization application form

    Exercise on the application form
 

National applications at BfArM (Pr�fung nationaler Zulassungsantr�ge im BfArM)

  • Assessment process, e.g. efficacy (Wirksamkeitspr�fung)
  • Clinical Trial reports according to Annex one of Directive 2001/83, Clinical Summary and Overview, relevant aspects in the assessment of clinical part of the dossier, fixed combinations
  • Summary of Product Characteristics (SmPC)
  • Company Core Data Sheet
  • Package leaflet and consultation with target patient groups
  • Labelling (Kennzeichnung)
  • Specific BfArM requirements (Besonderheiten in den Anforderungen des BfArM und zugeh�rige Bekanntmachungen)
  • Labelling principles in national phases of EU procedures 
3 

Veterinary products 

  • Definitions
  • Veterinary Legislation in Germany, EU and globally
  • EMEA, CVMP, HMA and CMD(v), VICH, Animal Health Industry Associations
  • Specific aspects of the SmPC
  • Parts of a Dossier - Part I, II, IIIA Safety, IIIB Residues, IV
  • Withdrawal Periods
  • Ecotoxicity

Vaccines

  • Definitions and specific aspects
  • Combinations
  • Influenza vaccines
  • Authorization procedure (brief introduction)
  • Vaccine Antigen Master File (VAMF) 
5 

Advanced Therapies

  • Relevant Directives, Regulations, Guidelines
  • Definition and classification: advanced therapy medicinal products, tissue products, combined products
  • Authorization procedures
  • Incentives 
6  Blood products
  • Specific regulatory aspects for Blood components
  • Official Batch Release
  • Specific requirements for marketing authorization of blood products (example coagulation factors)
  • Plasma Master File

    Exercise on blood products

7 

Specific aspects in marketing applications procedures for herbal and homeopathic medicinal products (Arzneimittel der besonderen Therapierichtungen)

  • Definitions
  • Requirements (AMG, AMPr�fRL, pharmacopoeas)
  • Possible MAA/registration procedures and required data on S, Q, E
  • Herbal medicinal products, HMPWP, Botanical nomenclature, Extracts (labeling)
  • Homeopathic medicinal products: The homeopathic principle, manufacturing according to PhEur
  • Registration procedure
  • Anthroposophical products (brief introduction)

 
« back
 
page up print
 
Studiengang (M.D.R.A.)
Abschluß: Master of Drug
Regulatory Affairs
mehr Informationen »
DGRA-Fortbildungen:
DGRA Workshops:

28. - 29. August 2012
Update Workshop

27. November 2012
Therapeutische Vaccine

Jahreskongresse:

30. - 31. Mai 2012
DGRA-Jahreskongress 2012

mehr Fortbildungen »
Job-Börse:
Angebot vom 03.04.2012
Manager Regulatory Affairs/ Qualitätsmanagement

Angebot vom 30.03.2012
Senior Manager Regulatory Affairs (m/f) Pharmaceutical CMC

mehr Stellenangebote »
© 2011, DGRA e.V.
Letzte Aktualisierung am:
Dienstag, 08.02.2011